WENDY LOWRY: Open Payments
NPI 1306311311 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,151 in 162 payments from 13 companies in 2025. Trend: 2023 $2,206 · 2024 $1,831 · 2025 $2,151
Food & beverage: $2,144Education: $7
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $391 |
| Alkermes, Inc. | 20 | $378 |
| Vanda Pharmaceuticals Inc. | 25 | $333 |
| ABBVIE INC. | 27 | $263 |
| Otsuka America Pharmaceutical, Inc. | 11 | $156 |
| Axsome Therapeutics, Inc. | 17 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $139 |
| Corium, LLC | 5 | $91 |
| Tris Pharma Inc | 5 | $88 |
| Lundbeck LLC | 5 | $81 |
Products named: CAPLYTA, FANAPT, VRAYLAR, REXULTI, ARISTADA, LYBALVI, TRINTELLIX, Auvelity.
Industry payments across DE — which companies pay providers there.
